• Warhound raises $200 million for genetically engineered military dogs.
• The company plans to clone and edit dogs for improved performance and health.
• Founders include Palmer Luckey and Ben Lamm, with expertise in defense and biotechnology.
• Intended customers include US military forces, law enforcement, and first responders.

Warhound's $200 million seed round may indicate growing investor interest in defense biotechnology. The company's approach, combining cloning and gene editing, could potentially disrupt traditional breeding and training methods, but it also raises ethical and oversight concerns that may impact its success.